guidebook. - Fanconi Anemia Research Fund

164
Fanconi Anemia: Guidelines for Diagnosis and Management
36. Woodard TL, Burghen GA, Kitabchi AE, Wilimas JA. Glucose
intolerance and insulin resistance in aplastic anemia treated with
oxymetholone. Journal of Clinical Endocrinology and Metabolism
1981; 53: 905-908.
37. Wilson DM, Frane JW, Sherman B, et al. Carbohydrate and
lipid metabolism in Turner syndrome: effect of therapy with
growth hormone, oxandrolone and a combination of both. Journal
of Pediatrics 1988; 112: 210-217.
38. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme
gene expression in pancreatic islets compared with various other
mouse tissues. Free Radical Biology and Medicine 1996; 20: 463-
466.
39. Sigfrid LA, Cunningham JM, Beeharry N, et al. Antioxidant
enzyme activity and mRNA expression in the islets of Langerhans
from the BB/S rat model of type 1 diabetes and an insulin-producing
cell line. Journal of Molecular Medicine (Berlin, Germany)
2004; 82: 325-335.
40. Pagano G, Youssoufian H. Fanconi anaemia proteins: major
roles in cell protection against oxidative damage. Bioessays 2003;
25: 589-595.
41. Yanovski JA, Rose SR, Municchi G, et al. Treatment with
a luteinizing hormone-releasing hormone agonist in adolescents
with short stature. New England Journal of Medicine 2003; 348:
908-17.
42. Rose SR. Induction of puberty in female hypogonadism. The
Endocrinologist 1996; 6: 439-442.
43. Alter BP, Frissora CL, Halpérin DS, et al. Fanconi’s anaemia
and pregnancy. British Journal of Haematology 1991; 77: 410-418.